in an international multicentre controlled single-blind trial of 93 previously untreated lepromatous leprosy patients the therapeutic effects of adding rifampicin , 450 mg/day orally or 1,200 mg once monthly in a single oral dose , to dapsone ( 50 mg/day orally ) for the first 6 months of treatment were compared .
C0023348
lepromatous leprosy
C0010980
dapsone